Three independent discounted-cash-flow-style models value Harmony Biosciences Holdings, Inc. Common Stock every trading day. 2 of 3 currently price HRMY above its market price.
| Free Cash Flow model | $63.50 |
| Excess Profit model | $100.11 |
| Residual Earnings model | $30.43 |
| Dividend Discount model | — |
| Piotroski F-Score | 6 / 9 |
| Return on invested capital | +15.9% |
| Net debt / EBITDA | -2.8× |
| Gross margin | +77.2% |
| Revenue CAGR | +25.6% |
| Cash conversion | 2.2× |
| Dividend yield | — |
| Buyback yield | -1.1% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open HRMY in StockKitty